Claim Missing Document
Check
Articles

Found 2 Documents
Search

Oral health management in hypertensive patients addressing coated tongue caused by antihypertensive medication use: a case report Tanumiharja, Marvin Jaya Setiadi; Tanumiharja, Leonardo Jaya Setiadi; Lelyana, Shelly; Kamil, Seno Muhammad
Padjadjaran Journal of Dentistry Vol 37, No 1 (2025): April 2025 (Supplements 1)
Publisher : Universitas Padjadjaran

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24198/pjd.vol37no1.59318

Abstract

Introduction: Hypertension is a chronic condition characterized by elevated blood pressure, often accompanied by symptoms such as headaches, epistaxis, and palpitations. Coated tongue is a clinical condition in which the tongue's surface develops a pseudomembrane due to accumulated debris, non-desquamated keratin cells, and microorganisms, such as bacteria and fungi.  This study aims to explore the potential relationship between hypertension and coated tongue, emphasizing the importance of oral hygiene in hypertensive patients. By examining a clinical case, the research highlights the role of tongue cleaning in managing coated tongue and improving oral health. Additionally, it underscores the need for patient education and adherence to proper oral hygiene practices to achieve better treatment outcomes.Case Report: A 49-year-old female patient presented to Sartika Asih Bhayangkara Hospital with complaints of persistent bad breath for one month. She reported white spots on her tongue causing discomfort but no pain. The patient reported brushing her teeth one to two times daily but had never cleaned her tongue. She had a history of hypertension and was one amlodipine therapy.Conclusion: Coated tongue in hypertensive patients can be managed through regular tongue cleaning after brushing. Effective communication, education, and patient cooperation are crucial for optimal treatment outcomes.
Effect of Postoperative Methylprednisolone on Swelling and Pain After Mandibular Third Molar Surgery: A Randomized Controlled Trial Tanumiharja, Leonardo Jaya Setiadi; Situmorang, Gabriella Debora Alvionita; Sumaji, Borman; Lesmana, Dian
Journal of Applied Nursing and Health Vol. 8 No. 1 (2026): Journal of Applied Nursing and Health
Publisher : Chakra Brahmanda Lentera Institute

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55018/janh.v8i1.483

Abstract

Background: Pain and swelling are common inflammatory complications following mandibular third molar surgery. Corticosteroids are widely used to control postoperative inflammation and improve patient comfort. However, evidence regarding the effectiveness of low-dose postoperative methylprednisolone, particularly at an 8 mg dose, remains limited, especially in low- and middle-income countries (LMICs). This study aimed to evaluate the effectiveness of an 8 mg dose of methylprednisolone on postoperative pain intensity and facial swelling following surgery. Methods: This study employed a parallel-group, two-arm randomized controlled trial design conducted in accordance with the CONSORT guidelines. A total of 30 patients who met the inclusion criteria were randomly assigned to either the intervention group (8 mg methylprednisolone) or the control group (standard care), with 15 participants in each group. The independent variable was methylprednisolone administration, while the dependent variables included pain intensity measured using the Visual Analog Scale (VAS) and facial swelling. Outcome assessments were performed on postoperative days 1, 3, and 7. Statistical analyses were used for independent t-tests. Results: Pain intensity was lower in the methylprednisolone group than in the control group at all postoperative time points, with large between-group effect sizes observed on day 1 (p = 0.003; Cohen’s d = 1.42), day 3 (p = 0.020; Cohen’s d = 1.36), and day 7 (p = 0.007; Cohen’s d = 1.18). Facial swelling also differed between groups, showing a lower degree of swelling in the methylprednisolone group during postoperative days 1–3 (p = 0.029; Cohen’s d = 0.98) and days 3–7 (p = 0.002; Cohen’s d = 0.87), indicating consistently large effects across outcomes. Conclusion: Low-dose methylprednisolone is statistically and clinically effective in reducing postoperative pain and swelling following surgery and may be integrated as a safe and cost-effective adjuvant therapy in postoperative dental care.